More

    Finance

    Breeze Airways CEO David Neeleman: air travel remains ‘unbelievably safe’ and AI will change the game

    It’s a tense moment for air travel. As consumers grow increasingly weary of bad customer service experiences, Boeing’s frightening safety failures of the...

    Rep. Adam Schiff calls on Biden to drop out of election

    Rep. Adam Schiff (D-CA) appears on "Meet the Press" in Washington D.C., Sunday July 7, 2024. William Plowman | Nbcuniversal | Getty ImagesCalifornia Democratic...

    SoundThinking rebuts NYC audit on ShotSpotter efficacy By Investing.com

    FREMONT, Calif. - SoundThinking, Inc. (NASDAQ:SSTI), a company specializing in public safety technology, has issued a response to the New York City Comptroller's...

    Getting to the moon is a ‘moral obligation’ to preserve humanity, space tech executives from Astrolab and Stoke say

    Once dominated by government agencies like NASA, the space race ecosystem is increasingly run by private companies including Elon Musk’s SpaceX and Jeff...

    Stocks making the biggest moves midday: NVDA, JNJ, SG, GTLB

    Check out the companies making headlines in midday trading. Chip stocks — Several large chip stocks fell after Bloomberg News reported that said...

    Immutep gets green light for Phase I autoimmune study By Investing.com

    Today, Immuno-oncology company IMMUTEP Ltd (NASDAQ:IMMP) announced it has received regulatory clearance to commence a Phase I clinical trial for its novel LAG-3...

    The nation’s 911 system is on the brink of its own emergency

    A scramble to handle the crisis was on. Police texted out administrative numbers that callers could use, Boston Mayor Michelle Wu gave outage updates...

    What 2024 VP picks could mean for Social Security

    Trump's pick for Vice President, U.S. Sen. J.D. Vance (R-OH) arrives on the first day of the Republican National Convention at the Fiserv...

    Alterity reports positive Phase 2 trial interim data By Investing.com

    Alterity Therapeutics Limited, a pharmaceutical company specializing in the development of treatments for neurodegenerative diseases, announced positive interim data from its Phase 2...

    Latest articles

    spot_imgspot_img